Crossmark

Relative effectiveness and safety of interleukin-6 and Janus kinase inhibitors versus adalimumab in patients with rheumatoid arthritis: a network meta-analysis

Crossref DOI link: https://doi.org/10.1007/s00393-022-01290-6

Published Online: 2022-11-24

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, Young Ho

Song, Gwan Gyu
License Information

Text and Data Mining valid from 2022-11-24

Version of Record valid from 2022-11-24
More Information

Article History

Accepted: 10 October 2022

First Online: 24 November 2022

Declarations

:

: Y.H. Lee and G.G. Song declare that they have no competing interests.

: An ethics statement is not applicable because this study is based exclusively on published literature.

Document is current

Any future updates will be listed below